Last Posted: Mar 12, 2020
- Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study.
Archer Stephanie et al. PloS one 2020 15(3) e0229999 - Genetic testing for epithelial ovarian cancer.
Amin Noa et al. Best practice & research. Clinical obstetrics & gynaecology 2020 Jan - Prevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan.
Alvarado Mónica et al. Journal of community genetics 2020 Feb - Frequency of BRCA1 and BRCA2 Mutations in Individuals with Breast and Ovarian Cancer in a Chinese Hakka Population Using Next-Generation Sequencing.
Wu Heming et al. Human heredity 2020 Feb 1-10 - Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer.
Chen Bo et al. Aging 2020 Feb 12 - The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort.
Hu Chunling et al. Journal of the National Cancer Institute 2020 Feb - Germline mutation in 1,338 BRCA-negative Chinese hereditary breast and/or ovarian cancer patients: clinical testing with a multigene test panel.
Kwong Ava et al. The Journal of molecular diagnostics : JMD 2020 Feb - [Hereditary breast and ovarian cancer syndrome: Diagnosis and therapeutic implications].
Koual Meriem et al. Annales de pathologie 2020 Feb - A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.
Cortesi Laura et al. Cancer medicine 2020 Feb - Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?
Angeli Davide et al. International journal of molecular sciences 2020 Feb 21(3)
.png)
No hay comentarios:
Publicar un comentario